---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-285426"
form_type: "8-K"
ticker: "ALGS"
cik: "0001799448"
company_name: "Aligos Therapeutics, Inc."
filed_at: "2026-06-26T20:02:26+00:00"
generated_at: "2026-06-26T20:03:59.768379+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Aligos stockholders reelect two Class III directors, approve ESPP amendment adding 500K shares

## Summary
- Bridget Martell and Carole Nuechterlein elected as Class III directors with 2,092,164 and 2,086,481 votes for, respectively.
- Stockholders approved ESPP amendment increasing share reserve by 500,000 shares to 694,714 total, and eliminating evergreen provision.
- Ratification of Ernst & Young as auditor for fiscal 2026 approved with 3,786,255 votes for.
- Non-binding advisory say-on-pay approved with 2,074,434 votes for; company will hold future advisory votes annually.
- Stockholders voted 2,077,884 for annual frequency of say-on-pay; board adopts annual vote until next advisory vote.

## SEC filing metadata
- accession: 0001193125-26-285426
- form_type: 8-K
- ticker: ALGS
- cik: 0001799448
- company_name: Aligos Therapeutics, Inc.
- filed_at: 2026-06-26T20:02:26+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799448/000119312526285426/0001193125-26-285426-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799448/000119312526285426/d70452d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-285426
- JSON: https://secwatch.observer/filing/0001193125-26-285426.json
- Plain text: https://secwatch.observer/filing/0001193125-26-285426.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.